Cargando…
2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan
BACKGROUND: To manage antimicrobial resistance, both antimicrobial stewardship (AMS) and antifungal stewardship (AFS) are needed. However, limited data show AMS and AFS practices among hospitals in Japan. METHODS: We conducted a cross-sectional nationwide study using a questionnaire distributed to h...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810760/ http://dx.doi.org/10.1093/ofid/ofz360.1712 |
_version_ | 1783462321436229632 |
---|---|
author | Moriyama, Yuki Ishikane, Masahiro Kusama, Yoshiki Matsunaga, Nobuaki Tajima, Taichi Hayakawa, Kayoko Ohmagari, Norio |
author_facet | Moriyama, Yuki Ishikane, Masahiro Kusama, Yoshiki Matsunaga, Nobuaki Tajima, Taichi Hayakawa, Kayoko Ohmagari, Norio |
author_sort | Moriyama, Yuki |
collection | PubMed |
description | BACKGROUND: To manage antimicrobial resistance, both antimicrobial stewardship (AMS) and antifungal stewardship (AFS) are needed. However, limited data show AMS and AFS practices among hospitals in Japan. METHODS: We conducted a cross-sectional nationwide study using a questionnaire distributed to hospitals that participated in a hospital epidemiology workshop in Japan in July 2018. The questions addressed activities of preauthorization, notification, and intervention within 7 or 28 days about broad-spectrum antibiotics (third- and fourth-generation cephalosporins and piperacillin–tazobactam, carbapenem, intravenous quinolone) and antifungals. Interventions to use broad-spectrum antibiotics and antifungals were compared between large (≥501 beds) and small/medium-sized (≤500 beds) hospitals. RESULTS: Of 240 hospitals, 39 (16%; 18 large and 21 small/medium-sized) responded. Preauthorization of using broad-spectrum antibiotics and antifungals was found in 4 (10%) and 1 (3%) hospital(s), respectively. Notification of broad-spectrum antibiotics and antifungals was found in 37 (95%) and 2 (5%) hospitals, respectively. The numbers of hospitals that intervened in the use of broad-spectrum antibiotics within 7 and 28 days were 17 (44%) and 34 (87%), respectively; those of antifungals were 3 (8%) and 10 (26%), respectively (Table 1). Interventions to use broad-spectrum antibiotics within 7 days were statistically more frequent in small-/medium-sized hospitals than in large hospitals [13 (61.9%) vs. 4 (22.2%),odds ratio = 5.7, 95% confidence interval = 1.4–23.3, p = 0.023]. All hospitals had less-frequent interventions to use antifungals within 7 days than those for antibiotics[3 (14.3%) vs. 0 (0%)] (Table 2). CONCLUSION: Small-/middle-sized hospitals had more frequent interventions within 7 days of broad-spectrum antibiotics than those of large hospitals, possibly because small-/medium-sized hospitals are agile and have few barriers against interventions to use broad-spectrum antibiotics. Compared with broad-spectrum antibiotics, interventions of antifungals were less frequently conducted in all hospitals. We need to emphasize the importance of AFS in Japan. Further studies on related factors are needed. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68107602019-10-28 2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan Moriyama, Yuki Ishikane, Masahiro Kusama, Yoshiki Matsunaga, Nobuaki Tajima, Taichi Hayakawa, Kayoko Ohmagari, Norio Open Forum Infect Dis Abstracts BACKGROUND: To manage antimicrobial resistance, both antimicrobial stewardship (AMS) and antifungal stewardship (AFS) are needed. However, limited data show AMS and AFS practices among hospitals in Japan. METHODS: We conducted a cross-sectional nationwide study using a questionnaire distributed to hospitals that participated in a hospital epidemiology workshop in Japan in July 2018. The questions addressed activities of preauthorization, notification, and intervention within 7 or 28 days about broad-spectrum antibiotics (third- and fourth-generation cephalosporins and piperacillin–tazobactam, carbapenem, intravenous quinolone) and antifungals. Interventions to use broad-spectrum antibiotics and antifungals were compared between large (≥501 beds) and small/medium-sized (≤500 beds) hospitals. RESULTS: Of 240 hospitals, 39 (16%; 18 large and 21 small/medium-sized) responded. Preauthorization of using broad-spectrum antibiotics and antifungals was found in 4 (10%) and 1 (3%) hospital(s), respectively. Notification of broad-spectrum antibiotics and antifungals was found in 37 (95%) and 2 (5%) hospitals, respectively. The numbers of hospitals that intervened in the use of broad-spectrum antibiotics within 7 and 28 days were 17 (44%) and 34 (87%), respectively; those of antifungals were 3 (8%) and 10 (26%), respectively (Table 1). Interventions to use broad-spectrum antibiotics within 7 days were statistically more frequent in small-/medium-sized hospitals than in large hospitals [13 (61.9%) vs. 4 (22.2%),odds ratio = 5.7, 95% confidence interval = 1.4–23.3, p = 0.023]. All hospitals had less-frequent interventions to use antifungals within 7 days than those for antibiotics[3 (14.3%) vs. 0 (0%)] (Table 2). CONCLUSION: Small-/middle-sized hospitals had more frequent interventions within 7 days of broad-spectrum antibiotics than those of large hospitals, possibly because small-/medium-sized hospitals are agile and have few barriers against interventions to use broad-spectrum antibiotics. Compared with broad-spectrum antibiotics, interventions of antifungals were less frequently conducted in all hospitals. We need to emphasize the importance of AFS in Japan. Further studies on related factors are needed. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810760/ http://dx.doi.org/10.1093/ofid/ofz360.1712 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Moriyama, Yuki Ishikane, Masahiro Kusama, Yoshiki Matsunaga, Nobuaki Tajima, Taichi Hayakawa, Kayoko Ohmagari, Norio 2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan |
title | 2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan |
title_full | 2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan |
title_fullStr | 2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan |
title_full_unstemmed | 2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan |
title_short | 2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan |
title_sort | 2032. first national survey of antimicrobial and antifungal stewardship in japan |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810760/ http://dx.doi.org/10.1093/ofid/ofz360.1712 |
work_keys_str_mv | AT moriyamayuki 2032firstnationalsurveyofantimicrobialandantifungalstewardshipinjapan AT ishikanemasahiro 2032firstnationalsurveyofantimicrobialandantifungalstewardshipinjapan AT kusamayoshiki 2032firstnationalsurveyofantimicrobialandantifungalstewardshipinjapan AT matsunaganobuaki 2032firstnationalsurveyofantimicrobialandantifungalstewardshipinjapan AT tajimataichi 2032firstnationalsurveyofantimicrobialandantifungalstewardshipinjapan AT hayakawakayoko 2032firstnationalsurveyofantimicrobialandantifungalstewardshipinjapan AT ohmagarinorio 2032firstnationalsurveyofantimicrobialandantifungalstewardshipinjapan |